chondrocelect
tigenix n.v. - characterised viable autologous cartilage cells expanded ex vivo expressing specific marker proteins - cartilage diseases - other drugs for disorders of the musculo-skeletal system - repair of single symptomatic cartilage defects of the femoral condyle of the knee (international cartilage repair society [icrs] grade iii or iv) in adults.concomitant asymptomatic cartilage lesions (icrs grade i or ii) might be present. demonstration of efficacy is based on a randomised controlled trial evaluating the efficacy of chondrocelect in patients with lesions between 1 and 5 cm².
maci
vericel denmark aps - autologous cultured chondrocytes - fractures, cartilage - other drugs for disorders of the musculo-skeletal system - repair of symptomatic cartilage defects of the knee.
spherox
co.don gmbh - spheroids of human autologous matrix-associated chondrocytes - cartilage diseases - other drugs for disorders of the musculo-skeletal system - repair of symptomatic articular cartilage defects of the femoral condyle and the patella of the knee (international cartilage repair society [icrs] grade iii or iv) with defect sizes up to 10 cm2 in adults.,
alflutop solution for injection
s.c.biotehnos s.a. - bioactive concentrate from small sea fish - solution for injection - 0,1ml/ml
alflutop solution for injection
s.c.biotehnos s.a. - bioactive concentrate from small sea fish - solution for injection - 0,1ml/ml
mesoestetic mesofiller intense solution for injection
mesoestetic pharma group s.l, spain - hyaluronic acid - solution for injection - 25 mg/ml